Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Journal of Immunology Research|May 27, 2014
Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinomaSu-xia Han, E Bai, Gui-hua Jin, et al.Diagnostic Pathology|August 7, 2013
Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysisXia Ying, Su-xia Han, Jun-lan Wang, et al.European Journal of Pharmacology|February 22, 2023
Metformin enhances T lymphocyte anti-tumor immunity by increasing the infiltration via vessel normalizationGuang-Yue Li, Yue-Qi Feng, Yi-Fan Jia, et al.Oncogene|December 14, 2018
NTRK1 is a positive regulator of YAP oncogenic functionXinyuan Yang, He Shen, Brian Buckley, et al.Oncology Reports|April 27, 2013
The role of CDK1 in apoptin-induced apoptosis in hepatocellular carcinoma cellsJing Zhao, Su-Xia Han, Jin-Lu Ma, et al.Journal of Immunology Research|May 27, 2014
Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinomaSu-xia Han, Jun-lan Wang, Xi-jing Guo, et al.Cancer Medicine|October 26, 2018
High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinomaCong-Ya Zhou, Yi-Ping Dong, Xiao Sun, et al.Oncotarget|March 25, 2015
MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTENLi-Juan Wang, Chen-Chen He, Xin Sui, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 22, 2014
The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasisSu-xia Han, Jing Wang, Li-juan Wang, et al.Oncology Reports|August 12, 2014
Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinomaXia Ying, Yue Zhao, Jun-Lan Wang, et al.Pageof 4